JUNIPER PHARMACEUTICALS INC's ticker is JNP and the CUSIP is 48203L107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $3,191,000 | -12.1% | 366,751 | +2.6% | 0.03% | -17.9% |
| Q1 2018 | $3,630,000 | +109.3% | 357,600 | 0.0% | 0.04% | +105.3% |
| Q4 2017 | $1,734,000 | +28.8% | 357,600 | +20.9% | 0.02% | +26.7% |
| Q3 2017 | $1,346,000 | +25.3% | 295,800 | +39.1% | 0.02% | +15.4% |
| Q2 2017 | $1,074,000 | +25.5% | 212,700 | +18.0% | 0.01% | +30.0% |
| Q1 2017 | $856,000 | -15.2% | 180,200 | 0.0% | 0.01% | -23.1% |
| Q4 2016 | $1,009,000 | +0.9% | 180,200 | 0.0% | 0.01% | -13.3% |
| Q3 2016 | $1,000,000 | -20.8% | 180,200 | 0.0% | 0.02% | -25.0% |
| Q2 2016 | $1,263,000 | +34.6% | 180,200 | +27.0% | 0.02% | +25.0% |
| Q1 2016 | $938,000 | -9.7% | 141,850 | +40.6% | 0.02% | -15.8% |
| Q4 2015 | $1,039,000 | – | 100,900 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 481,459 | $5,672,000 | 2.05% |
| Krensavage Asset Management, LLC | 279,717 | $3,295,000 | 1.19% |
| EAM Investors, LLC | 145,898 | $1,719,000 | 0.27% |
| PERRITT CAPITAL MANAGEMENT INC | 93,000 | $1,096,000 | 0.23% |
| TFS CAPITAL LLC | 99,823 | $1,176,000 | 0.11% |
| Bellevue Asset Management AG | 50,000 | $589,000 | 0.10% |
| CADENCE CAPITAL MANAGEMENT LLC | 88,232 | $1,039,000 | 0.07% |
| Spark Investment Management LLC | 39,200 | $461,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 100,564 | $1,185,000 | 0.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 35,599 | $419,000 | 0.03% |